A recent report from Renub Research, titled "Global Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," offers a thorough analysis of the industry and market share knowledge. The report also includes research on regions, competitors, and the recent expansion of the Global Vaccine Market.

1. Global Vaccine Market is
expected to grow to USD
92.32 billion by 2028
Base Year: 2022
Market Research & Advisory

2. 2
2
Global Vaccine Market
A recent report from Renub Research, titled "Global Vaccine Market: Global Industry Trends, Share, Size,
Growth, Opportunity, and Forecast 2023-2028," offers a thorough analysis of the industry and market share
knowledge. The report also includes research on regions, competitors, and the recent expansion of the Global
Vaccine Market.
Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/global-
vaccines-market-and-forecast-14-vaccines-market-number-of-people-immunized-doses-of-vaccines-
administered-1200-p.php
Between 2022 and 2028, the Global Vaccine Market is anticipated to expand at a CAGR of 8.64%.The global health
has greatly benefited from vaccination. Smallpox and rinderpest have both been completely eliminated. Since the
establishment of the WHO’s Expanded Programme of Immunization and the Global Alliance for Vaccine and
Immunization, vaccination coverage against many serious infectious diseases of children has increased dramatically
on a global scale. The eradication of polio is almost complete, and the success in controlling measles makes it a
potential candidate for eradication.
2
https://www.renub.com

3. 3
3
Global Vaccine Market
Despite these accomplishments, 6.6 million kids still pass away from preventable diseases like pneumonia and
diarrhea each year, accounting for about half of all pediatric fatalities, according to the NCBI. Therefore, increased
use of the rotavirus and pneumococcal conjugate vaccines should result in more children living longer. Some non-
infectious diseases may eventually be prevented or treated differently thanks to vaccines. Progress has already
been made with therapeutic cancer vaccines; upcoming potential targets include addiction, diabetes, hypertension,
and Alzheimer's disease.
Governments all over the world are now aware of how crucial vaccination programs are to lowering the prevalence
of infectious diseases. As a result, numerous nations have put in place extensive immunization campaigns to reach
at-risk populations and stop outbreaks. The demand for vaccines is being boosted by these governmental initiatives.
This is in line with the continued serious concern over the high child mortality rate caused by infectious diseases,
especially in developing nations. To combat this problem, vaccination campaigns are being stepped up in these
areas, driving up demand for vaccines. As a result of the participation of numerous international organizations and
foundations, the market for vaccines in endemic areas is growing.
3
https://www.renub.com

4. 4
4
Global Vaccine Market
The last ten years have seen significant advancements in vaccine technology, which have significantly altered the
course of vaccine development. In vaccine development programs, the introduction of genetic engineering has
sparked numerous advancements that have produced new goods. These techniques have been used to create a
number of virus vaccines that utilize the virus's attenuated form. New technologies also make it possible to detect
viruses more quickly and maintain concentration levels that are high enough to trigger an immune response.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=global-
vaccines-market-and-forecast-14-vaccines-market-number-of-people-immunized-doses-of-vaccines-
administered-1200-p.php
The pneumococcal vaccine is anticipated to maintain a sizable share of the Global Vaccine Market.
The pneumococcal vaccine commands a sizable portion of the Global Vaccine Market because it is effective in
preventing a number of serious illnesses caused by the Streptococcus pneumoniae bacteria. Pneumonia,
meningitis, otitis media, and invasive pneumococcal disease (IPD) are a few of these, and they can all be fatal,
especially in vulnerable populations like young children and the elderly. The vaccine also helps prevent less severe
conditions like sinusitis and bronchitis.
4
https://www.renub.com

5. 5
5
Global Vaccine Market
Vaccine Market Share – Global Vaccine Market has been covered from 14 viewpoints:
1. Influenza 2. HPV 3. Zoster 4. MMR
5. Pneumococcal 6. Meningococcal 7. Hepatitis 8. DTap/Tdap
9. Travel & Miscellaneous 10. HIB 11. Combos 12. Polio
13. Rotavirus 14. Varicella
In the near future, it is anticipated that influenza vaccines will continue to hold a significant position on the
Global Vaccine Market.
The high incidence of influenza among the elderly and those with underlying medical conditions generates
significant demand. Patients and parents are drawn to the vaccine because of how well it prevents serious
complications and how safe it is. The rise in demand has also been aided by increased government support and
public awareness of influenza and its prevention. Their acceptance has grown as a result of the creation of fresh,
improved vaccines like the quadrivalent influenza shot. The seasonal variation of the influenza virus, the disease's
global spread, and manufacturer competition all help to sustain market growth.
5
https://www.renub.com

6. 6
6
Global Vaccine Market
Vaccinated People – Global Vaccine Market has been covered from 13 viewpoints:
1. Influenza 2. Cervical Cancer 3. Zoster 4. MMR
5. Pneumococcal 6. Meningococcal 7. Hepatitis 8. DTap/Tdap
9. HIB 10. Combos 11. Polio 12. Rotavirus
13. Varicella
The Global Vaccine Market is anticipated to remain dominated by the United States in the years to come.
The United States maintains its leadership in the global vaccination industry thanks to a solid R&D foundation that
includes top universities and pharmaceutical companies and keeps it in front of vaccine development. A sizable,
tightly controlled vaccine market also draws investment and keeps up demand. Government assistance strengthens
the vaccine industry further by providing funding and advocating for vaccination. The US is still a significant player in
the global market thanks to its extensive reach and a history of successful vaccine development and production.
The country continues to lead due in part to its high vaccination rates, rising vaccination rates awareness, and
improvements in vaccine technology.
6
https://www.renub.com

7. 7
7
Global Vaccine Market
Country – Global Vaccine Market has been covered from 21 viewpoints:
1. United States 2. Canada 3. Mexico 4. United Kingdom
5. Germany 6. France 7. Russia 8. Italy
9. Spain 10. Switzerland 11. India 12. China
13. Japan 14. Australia 15. South Korea 16. Brazil
17. Argentina 18. Saudi Arabia 19. UAE 20. South Africa
21. Rest of the World
Market and volume growth for pediatric vaccines are anticipated in the upcoming years.
Global demand for pediatric vaccines is rising as people become more aware of the value of immunization,
particularly for children. Pediatric vaccines are also necessary to protect children from infectious diseases like
measles and mumps, which are becoming more common. The creation of more recent and secure vaccines has
also increased demand. Government support, including financial aid, improves children's access to vaccines.
Improved cold chain management also guarantees vaccine availability and reduces waste. The pediatric vaccine
market is also growing as a result of factors like rising birth rates, increased urbanization, and rising wealth.
7
https://www.renub.com

8. 8
8
Global Vaccine Market
Category – Global Vaccine Market has been covered from 2 viewpoints:
1. Adult 2. Pediatric
Competitive Landscape.
AstraZeneca plc, Sanofi Pasteur, Pfizer Inc., CSL Limited, and GlaxoSmithKline plc are a few of the top businesses
vying for market share in the Global Vaccine Market.
Company Insights:
• Overview • Recent Development and Initiatives • Sales Analysis
Company Analysis:
1. GlaxoSmithKline plc 2. AstraZeneca plc 3. Sanofi Pasteur
4. Pfizer Inc. 5. CSL Limited
8
https://www.renub.com

9. S
O U T
A U
B
9
https://www.renub.com
Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in
Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy,
organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000
syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to
EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings
and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research